Island Pharmaceuticals Ltd (ILA) — Financial Flexibility Index
Island Pharmaceuticals Ltd (ILA) has a Financial Flexibility Index of -5.03x as of June 2025. Free cash flow of AU$-1.69 Million (operating CF AU$-1.69 Million minus capex AU$5.00) represents -5% of total liabilities (AU$336.43K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Island Pharmaceuticals Ltd Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Island Pharmaceuticals Ltd across 6 annual periods. See Island Pharmaceuticals Ltd (ILA) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Island Pharmaceuticals Ltd (2019–2024)
Year-by-year free cash flow to debt coverage for Island Pharmaceuticals Ltd. For the full company profile including market capitalisation, see Island Pharmaceuticals Ltd (ILA) total market value.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -8.23x | AU$-2.77 Million | AU$-2.77 Million | AU$336.43K | ▼ -171.9% |
| 2023 | -3.03x | AU$-3.16 Million | AU$-3.16 Million | AU$1.05 Million | ▲ +70.5% |
| 2022 | -10.27x | AU$-2.71 Million | AU$-2.71 Million | AU$263.85K | ▼ -217.5% |
| 2021 | -3.23x | AU$-1.88 Million | AU$-1.88 Million | AU$580.73K | ▲ +18.4% |
| 2020 | -3.96x | AU$-938.23K | AU$-938.24K | AU$236.83K | ▼ -16588.4% |
| 2019 | -0.02x | AU$-16.00 | AU$-16.00 | AU$674.00 | — |